An estimated 40,000 children in sub-Saharan Africa have cancer or a hematological disorder and only 20 percent of those children survive. That’s compared to 80 percent of U.S. children diagnosed with cancer that survive.
Texas Children’s aims to change this dismal news by bringing its world-class pediatric specialists and stellar care and treatment programs where it’s needed most.
Texas Children’s Global Health placed its first pediatric cancer specialist in Africa in 2007. Working at the request of Dr. Haruna Jibril, then head of pediatrics at Princess Marina Hospital in Gaborone, Botswana, Dr. Parth Metha arrived from Texas Children's Cancer & Hematology Centers
Today, Texas Children’s has physicians working in Angola, Botswana, Malawi and Uganda, and is developing the first pediatric cancer hospital in sub-Saharan Africa, the Botswana Children’s Cancer Center of Excellence in Gaborone. In Malawi, it provides pediatric hematology and oncology services at Kamuzu Central Hospital in Lilongwe, Malawi, in the country’s first hematology/oncology inpatient ward and outpatient clinic. 
Texas Children’s also coordinates the first pediatric hematology/oncology training program for East Africa in partnership with the Uganda Cancer Institute, Makere University and the Uganda Ministry of Health. The 2-year fellowship aims to build a critical mass of pediatric hematology-oncology specialists who will provide effective, locally-appropriate, evidence-based care in the African setting.


Dr. Gladstone Airewele
Director, Global Hematology Program
Assistant Professor of Pediatrics, Hematology & Oncology
Dr. Parth Mehta
Director, Global Oncology Program
Assistant Professor of Pediatrics, Hematology & Oncology
Dr. Alan Anderson
Associate Professor of Pediatrics, Hematology & Oncology
Dr. Joseph Lubega
Assistant Professor of Pediatrics, Hematology & Oncology
Dr. Judith Margolin
Co-Director, Vascular Anomalies Program
Associate Professor of Pediatrics, Hematology & Oncology
Dr. Jeremy Slone
Assistant Professor of Pediatrics, Hematology & Oncology
Dr. Damian Nirenberg
Director, Angola Sickle Cell Initiative
Assistant Professor of Pediatrics, Hematology & Oncology
Dr. Paz Noli
Global Health Corps Physician - Angola
Dr. Palka Patel
Global Health Corps Physician - Angola
Tamria Matondo, RN
Global Health Corps Nurse - Angola
Kristi Wilson-Lewis 
Director, Administration & Planning 
Ernest Fruge
Director, Psychosocial Programs
Mike Cubbage 
Assistant Director, Basic & Clinical Research and Core Laboratories 
Elise Ishigami, MPH 
Project Manager, Global Hematology & Oncology Programs

Global Hematology & Oncology Programs

Thousands of Angola’s children are born with sickle cell disease each year, and more than 50 percent die before age 5. Lack of diagnosis, lack of education on simple treatments to extend these children’s lives and lack of pediatric hematologists all contribute.

Texas Children’s works to improve the lives of children with sickle cell disease through the Angola Sickle Cell Initiative (ASCI). The program is a collaborative public-private partnership that provides screening, diagnosis, care, treatment, monitoring and evaluation, research, capacity building and community mobilization in Angola. The ASCI partnership includes the Angola Ministry of Health, Chevron Corporation, Texas Children's Hospital, Baylor College of Medicine and BIPAI. 
Based in Luanda and Cabinda provinces, Texas Children’s provides newborn screening for sickle cell in select maternity hospitals, plus research, outpatient and inpatient management of children with sickle cell disease, and education and training for Angolan medical students and health professionals. 
Texas Children’s pediatric hematologists work with the Angolan government to develop national public health policies and guidelines that support families affected by sickle cell. Long-term, the program promotes sustainability by improving diagnostic and clinical capacity and health professional education and training.
Official partnership with the Botswana Ministry of Health to strengthen pediatric hematology and oncology care and treatment in Botswana and to establish the Botswana Children’s Cancer Center of Excellence. Approximately 360 children per year developing cancer in Botswana including the HIV related malignancies - primarily lymphoma and Kaposi sarcoma (KS) and over 700 children with hematological disorders and only 6% of cases of childhood cancer in Botswana are currently estimated to be identified and treated. Other partners include Princess Marina Hospital, University of Botswana School of Medicine and the Botswana-Baylor Children’s Clinical Centre of Excellence Trust.
Texas Children's currently provides the only pediatric oncologist in Botswana. The program has trained more than 50 nurses and nursing students in pediatric hematology/oncology at Princess Marina Hospital. Approximately 50 new oncology patients and 100 new hematology patients receive care and treatment each year. Survival rates have increased almost 3-fold since the start of our program.
In partnership with the Uganda Ministry of Health, Uganda Cancer Institute, Mulago Hospital and Makere University, Texas Children’s has launched the East Africa Pediatric Hematology & Oncology Fellowship Training Program in 2016, the first of its kind in East Africa.